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Supplementary Figure S1: The flow cytometry analysis of EGFP expression in P19 cells following the 
viral transduction with the indicated vectors at different time points. The numbers in each plots 
represent the percentage of EGFP cells and the mean fluorescence intensity (in brackets). UNT: 
untransduced 
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Supplementary Figure S2: The CpG methylation on the SFFV LTR region in P19 cells following the 
lentiviral transduction. Genomic DNA from cells transduced with lentiviruses at day 17 was isolated and 
subjected to methylation analysis by bisulfite conversion and sequencing. Methylation status of randomly 
selected PCR colonies is shown. White boxes: unmethylated CpG sites. Black boxes: methylated CpG 
sites. Upper panel: SFFV-EGFP. Middle panel:: 527UCOE-SG. Lower panel: 455UCOE-SG. 
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Supplementary Figure S3: The 455UCOE region remains as an active chromatin domain compared 
to the 527UCOE region in murine P19 cells. The ChIP assay  was performed in P19 cells at day 10 post 
transduction. The value of enrichment for each antibody is determined relative to the input, IgG and 
normalized to the actively transcribed GAPDH or to the repressive mouse NGN1 locus. The data 
represents 2-3 repeated ChIP assays.  
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Supplementary Figure S4: The 455UCOE region remains as an active chromatin domain compared 
to the 527UCOE region in murine P19 cells. Enrichment of active and repressive histone marks and the 
MPP8 on the 455UCOE and the 527UCOE region was assessed by ChIP assay in P19 cells at day 17 post 
transduction. The value of enrichment for each antibodies is determined relative to the input, IgG and then 
normalized to the actively transcribed GAPDH or to the repressive mouse NGN1 locus. The normalized 
values of the enrichment at the 527UCOE, and the 455UCOE are shown. The data represents 2-3 
independent ChIP assays. P values are calculated by Student’s t-test. 
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Supplementary Figure S5:  Enrichment of CpG binding proteins Cfp1, KDM2A  on the 455UCOE 
and  the 527UCOE regions. The ChIP assay was performed in P19 cells at day 10 post transduction. The 
value of enrichment for each antibody is determined relative to the input, IgG and  then normalized to the 
actively transcribed GAPDH. The normalized values of the enrichment at the 527UCOE, and the 
455UCOE are shown . The data represents three independent ChIP assay.  P values are calculated by 
Student’s t-test.  
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Supplementary Table S1: Primers used in DNA methylation, Q-PCR and  ChIP analysis.  
* See the details in the materials and  methods. 
Methylation 
  
Forward 5’-3’ Reverse 5’-3’ 
Me-SFFV 
1st PCR 
TAGAAAAAGGGGGGAATGAAA 
  
AAACAACTCCTCACCCTTACTCA 
C 
Me-SFFV 
2nd PCR 
GGGGGAATGAAAGATTTTATT TG ACCCTTACTCACCATAATTTC AA CC 
Chimeric GGAGGAGGGAGTATAGTAGTA 
  
CAAACCAACTCAAACCCAATAC 
Q-PCR 
  
    
Lenti-PSI CAGGACTCG GCTTGCTGAAG TCCCCCGCTTAATACTGACG 
  Probe:  FAM-CGCACGGCA AGA GGCGAGG 
TAMRA 
  
Mouse Titin AAAACGAGCAGTGACCTGAGG TTCAGTCATGCTGCTAGCGC 
  Probe: FAM TGCACGGAA TCTC 
GTCTCAGTC TAMRA 
  
Human 
Albumin 
GCTGCTATCTCTTGTGGGCTGT ACTCATGGGAGCTGCTGGTTC 
  Probe: VIC-CCT GTC ATG CCC ACA CAA 
ATC TCT CC TAMRA 
  
ChIP  
  
    
527ucoe GAAATGCGCTTTGTCTCGAA 
  
CCC CCC TTT TTC TGG AGA CTA* 
455ucoe AGTGACCGGAGTCTCCTC A 
  
CCC CCC TTT TTC TGG AGA CTA* 
SFFV AATCAGCCTGCTTCTCGCTTCT 
  
TGA ACA GCT CCT CGC CCT T 
h-GAPDH GCTACTAGCGGTTTTACGGGCG 
  
TGC GGC TGA CTG TCG AAC AGG 
h-Chrom.18 ACTCCCCTTTCATGCTTCTG 
  
AGGTCCCAGGACATATCCATT 
m-GAPDH TCC CCT CCC CCT ATC AGT TC 
  
GAC CCG CCT CAT TTT TGA AA  
m-NGN-1 TCCGTTTCCTGCGTTTCAA TGCTCTGGGCTGGCTGTC 
  
